
1. front cell infect microbiol. 2017 sep 20;7:416. doi: 10.3389/fcimb.2017.00416.
ecollection 2017.

pathogenic cd8+ cells cause increased levels vegf-a experimental
malaria-associated acute respiratory distress syndrome, therapeutic vegfr
inhibition effective.

pham tt(1), verheijen m(1), vandermosten l(1), deroost k(1), knoops s(1), van den
eynde k(2), boon l(3), janse cj(4), opdenakker g(1), van den steen pe(1).

author information: 
(1)laboratory immunobiology, department microbiology immunology, rega
institute medical research, ku leuven-university leuvenleuven, belgium.
(2)translational cell tissue research, ku leuven-university leuvenleuven, 
belgium.
(3)biocerosutrecht, netherlands.
(4)leiden malaria research group, department parasitology, leiden university
medical centerleiden, netherlands.

malaria severe disease kills 400,000 people year. malarial
complications main cause death include cerebral malaria and
malaria-associated acute respiratory distress syndrome (ma-ards). despite
antimalarial treatment, lethality rates ma-ards still 20 80%. 
patients develop pulmonary edema hemorrhages leukocyte extravasation 
the lungs. vascular endothelial growth factor-a (vegf-a) placental
growth factor (plgf) vascular permeability factors may involved the
disruption alveolar-capillary membrane, leading alveolar edema. we
demonstrated increased pulmonary vegf-a plgf levels lungs mice with
experimental ma-ards. depletion pathogenic cd8+ cells blocked pulmonary
edema abolished increase vegf-a plgf. however, neutralization of
vegf receptor-2 (vegfr-2) monoclonal antibody clone dc101 not
decrease pulmonary pathology. broader spectrum receptor tyrosine kinase
inhibitor sunitinib even increased lung pathology. data suggest the
increase alveolar vegf-a plgf cause rather consequence of
the pulmonary pathology experimental ma-ards therapeutic inhibition
of vegf receptors effective even contra-indicated.

doi: 10.3389/fcimb.2017.00416 
pmcid: pmc5627041
pmid: 29034214  [indexed medline]

